BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND SDHB, PGL4, 6390, ENSG00000117118, SDH1, SDHIP, SDH, IP AND Prognosis
38 results:

  • 1. EIF2Ss, a Novel c-Myc-Correlated Gene Family, is Associated with Poor prognosis and Immune Infiltration in pancreatic Adenocarcinoma.
    Cao Z; Jing Y; Cheng C; Wang F; Guan M; Zhang K; Jiao J; Ruan L; Chen Z
    Front Biosci (Landmark Ed); 2024 Mar; 29(3):119. PubMed ID: 38538250
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. PELI1: key players in the oncogenic characteristics of pancreatic cancer.
    Fei X; Zhu C; Liu P; Liu S; Ren L; Lu R; Hou J; Gao Y; Wang X; Pan Y
    J Exp Clin Cancer Res; 2024 Mar; 43(1):91. PubMed ID: 38528516
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Acylcarnitines promote gallbladder cancer metastasis through lncBCL2L11-THOC5-JNK axis.
    Yang Y; Li H; Liu K; Zou L; Xiang S; Geng Y; Li X; Qiu S; Yang J; Cui X; Li L; Li Y; Li W; Yan S; Liu L; Wu X; Liu F; Wu W; Chen S; Liu Y
    J Transl Med; 2024 Mar; 22(1):299. PubMed ID: 38519939
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. SERPINE2 promotes liver cancer metastasis by inhibiting c-Cbl-mediated EGFR ubiquitination and degradation.
    Zhang S; Jia X; Dai H; Zhu X; Song W; Bian S; Wu H; Chen S; Tang Y; Chen J; Jin C; Zhou M; Xie H; Zheng S; Song P
    Cancer Commun (Lond); 2024 Mar; 44(3):384-407. PubMed ID: 38407942
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Exosome-derived tRNA fragments tRF-GluCTC-0005 promotes pancreatic cancer liver metastasis by activating hepatic stellate cells.
    Chen W; Peng W; Wang R; Bai S; Cao M; Xiong S; Li Y; Yang Y; Liang J; Liu L; Yazdani HO; Zhao Y; Cheng B
    Cell Death Dis; 2024 Jan; 15(1):102. PubMed ID: 38291031
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. KIF20B and MET, hub genes of DIAPHs, predict poor prognosis and promote pancreatic cancer progression.
    Cao Z; Guan M; Cheng C; Wang F; Jing Y; Zhang K; Jiao J; Ruan L; Chen Z
    Pathol Res Pract; 2024 Feb; 254():155046. PubMed ID: 38266456
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Nuclear PLD1 combined with NPM1 induces gemcitabine resistance through tumorigenic IL7R in pancreatic adenocarcinoma.
    Fu D; Yan J; Zhang Z; Liu Y; Ma X; Ding J; Yang S; Zhao R; Chang A; Gao C; Liu J; Zhao T; Wang X; Huang C; Gao S; Ma Y; Tang B; Feng Y; Wang H; Hao J
    Cancer Biol Med; 2023 Jun; 20(8):599-626. PubMed ID: 37381714
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. EvIPqPCR, Target Circulating Tumorous Extracellular Vesicles for Detection of pancreatic cancer.
    Rasuleva K; Jangili KP; Akinlalu A; Guo A; Borowicz P; Li CZ; Sun D
    Anal Chem; 2023 Jul; 95(27):10353-10361. PubMed ID: 37339258
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Neuroglobin inhibits pancreatic cancer proliferation and metastasis by targeting the GNAI1/EGFR/AKT/ERK signaling axis.
    Wu F; He J; Deng Q; Chen J; Peng M; Xiao J; Zeng Y; Yi L; Li Z; Tian R; Jiang Z
    Biochem Biophys Res Commun; 2023 Jul; 664():108-116. PubMed ID: 37141638
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The stromal-tumor amplifying STC1-Notch1 feedforward signal promotes the stemness of hepatocellular carcinoma.
    Bai S; Zhao Y; Chen W; Peng W; Wang Y; Xiong S; Aruna ; Li Y; Yang Y; Chen S; Cheng B; Wang R
    J Transl Med; 2023 Mar; 21(1):236. PubMed ID: 37004088
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. EGR1 induces EMT in pancreatic cancer via a P300/SNAI2 pathway.
    Wang Y; Qin C; Zhao B; Li Z; Li T; Yang X; Zhao Y; Wang W
    J Transl Med; 2023 Mar; 21(1):201. PubMed ID: 36932397
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. KIF15 is essential for USP10-mediated PGK1 deubiquitination during the glycolysis of pancreatic cancer.
    Quan G; Xu J; Wang J; Liu X; Xu J; Jiang J
    Cell Death Dis; 2023 Feb; 14(2):137. PubMed ID: 36807568
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. KLF14 regulates the growth of hepatocellular carcinoma cells via its modulation of iron homeostasis through the repression of iron-responsive element-binding protein 2.
    Zhou H; Chen J; Fan M; Cai H; Dong Y; Qiu Y; Zhuang Q; Lei Z; Li M; Ding X; Yan P; Lin A; Zheng S; Yan Q
    J Exp Clin Cancer Res; 2023 Jan; 42(1):5. PubMed ID: 36600258
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Exosomal DNAJB11 promotes the development of pancreatic cancer by modulating the EGFR/MAPK pathway.
    Liu P; Zu F; Chen H; Yin X; Tan X
    Cell Mol Biol Lett; 2022 Oct; 27(1):87. PubMed ID: 36209075
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Hypoxia-induced exosomal circPDK1 promotes pancreatic cancer glycolysis via c-myc activation by modulating miR-628-3p/BPTF axis and degrading BIN1.
    Lin J; Wang X; Zhai S; Shi M; Peng C; Deng X; Fu D; Wang J; Shen B
    J Hematol Oncol; 2022 Sep; 15(1):128. PubMed ID: 36068586
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The m
    Zhang Y; Liu X; Wang Y; Lai S; Wang Z; Yang Y; Liu W; Wang H; Tang B
    Mol Cancer; 2022 Sep; 21(1):174. PubMed ID: 36056355
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Targeting CRABP-II overcomes pancreatic cancer drug resistance by reversing lipid raft cholesterol accumulation and AKT survival signaling.
    Yu S; Wang L; Che D; Zhang M; Li M; Naito M; Xin W; Zhou L
    J Exp Clin Cancer Res; 2022 Mar; 41(1):88. PubMed ID: 35260193
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. PD-L1 correlated gene expression profiles and tumor infiltrating lymphocytes in pancreatic cancer.
    Li J; Yin L; Chen Y; An S; Xiong Y; Huang G; Liu J
    Int J Med Sci; 2021; 18(14):3150-3157. PubMed ID: 34400885
    [No Abstract]    [Full Text] [Related]  

  • 19. EEF1A2 interacts with HSP90AB1 to promote lung adenocarcinoma metastasis via enhancing TGF-β/SMAD signalling.
    Jia L; Ge X; Du C; Chen L; Zhou Y; Xiong W; Xiang J; Li G; Xiao G; Fang L; Li Z
    Br J Cancer; 2021 Mar; 124(7):1301-1311. PubMed ID: 33473168
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. MTIF2 impairs 5 fluorouracil-mediated immunogenic cell death in hepatocellular carcinoma in vivo: Molecular mechanisms and therapeutic significance.
    Xu D; Wang Y; Wu J; Zhang Z; Chen J; Xie M; Tang R; Cheng C; Chen L; Lin S; Luo X; Zheng J
    Pharmacol Res; 2021 Jan; 163():105265. PubMed ID: 33129983
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.